New York Times Examines Hepatitis C Treatments
The New York Times today features an article outlining the various drug treatments that are available for hepatitis C. The newest hepatitis C treatment consists of a combination of ribavirin and pegylated interferon, a regimen that can eradicate the virus in more than 60% of patients. Other hepatitis C treatments currently in development include a protease inhibitor, a polymerase inhibitor and a ribozyme, which may cut the virus "like ... scissors" (Bain, New York Times, 5/14). The full article is available online.This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.